Leadingagevirginia.org
FOR MORE INFORMATION
with William Vaughan, BSN, RN
VP of Education & Clinical Affairs
JENNIFER HARDESTY Pharm.D., FASCP Chief Clinical Officer
The Medication Pass: Can We do Better? (part 2)
ROB SHULMAN BS, R.Ph., CGP, FASCP
Building on information presented in the
medication pass, the surveyor observes
Director of Consultant Pharmacy Services
June issue of the Pulse, we now look at
that a clinically stable resident receives her
two common misconceptions that can
Digoxin at 11:50 a.m. You're now the sur-
REBECCA OGDEN BSN, RN, CRNI
lead to the erroneous citing of medication
veyor … do you cite this as a medication
Corporate Account Manager
error? According to CMS guidance to sur-
veyors at F332, you should not.
Please do not hesitate to contact your Remedi
TIMING OF ADMINISTRATION
Consultant Pharmacist or Account Manager
Perhaps no aspect of the medication pass
The guidance instructs surveyors to "…
if you have any questions or concerns.
gets as much attention, from both survey-
Count a wrong time error if the medica-
ors and staff, as the actual timing of medi-
tion is administered 60 minutes earlier or
cation administration. Ask any nurse when
later than its scheduled time of administra-
it's acceptable to administer a medication
tion, BUT ONLY IF THAT WRONG TIME
scheduled for 10 a.m. and the universal
ERROR CAN CAUSE THE RESIDENT
response will be "anytime between 9 a.m.
DISCOMFORT OR JEOPARDIZE THE
and 11 a.m." I was taught this "one hour
RESIDENT'S HEALTH AND SAFETY [bold
before / one hour after" concept in nursing
type included in original text]. Counting a
school some 30 years ago and it remains
medication with a long half-life
entrenched in nursing practice today.
Ask any nurse when it's acceptable to
(e.g., digoxin) as a wrong time
administer a medication scheduled for 10
error when it is 15 minutes late
Strict adherence to this golden hour "rule"
a.m. and the universal response will be
is improper because this med-
"anytime between 9 a.m. and 11 a.m."
can, however, lead to the inappropriate
ication has a long half-life (be-
citing of timing errors. For example, an
yond 24 hours) and 15 minutes
order is written as follows: "Digoxin 0.125
has no significant impact on the resident.
milligrams po once per day." The order is
The same is true for many other wrong time
transcribed onto the medication adminis-
errors."1 This approach requires surveyors
tration record and the drug is scheduled to
to look beyond the arbitrary one hour time
be administered daily at 10 a.m. During the
continued on page 4
Taking a Breath: Understanding Inhalers
Prepared by: Sarah Brett, Pharm.D., Clinical Consultant Pharmacist
Asthma and chronic obstructive pulmonary disease (COPD) are both
capsule in the chamber needs to be loosened
common respiratory disorders that affect many of the residents for
– It is important not to pierce the capsule in the chamber of
whom we care. Many therapies used to treat these conditions require
these devices more than once in order to avoid degrading the
use of one of numerous inhaler devices available. Effectively admin-
gelatin capsule and allowing it to pass through the screen to
istering medications using each drug-delivery system is essential to
the resident's airway
ensure optimal maintenance and treatment. Understanding proper • Examples:
inhaler technique can also help in recognizing when a device may no
– Spiriva HandiHaler, Arcapta Neohaler, Foradil Aerolizer,
longer be an effective delivery system for a resident, and prompt a
Flovent Diskus, Serevent Diskus, Advair Diskus, Breo Ellip-
review to determine if there is a more appropriate choice.
ta, Incruse Ellipta, Anoro Ellipta, Arnuity Ellipta, Asmanex
Twisthaler, Pulmicort Flexhaler, Tudorza Pressair
Although there are many different inhaler therapies available, they
can be classified as either pressurized metered dose (pMDI), dry SOFT MIST INHALERS
powder (DPI), or soft mist inhalers. Each class has very similar key • New innovations - becoming more widely utilized drug-delivery
points for administration technique.
• Generate an aerosol without utilizing a propellant or relying on
PRESSURIZED METERED-DOSE INHALERS (PMDI)
the patient's inspiratory flow
• Are the most familiar, and include devices that contain the pro-
– A spring forces the solution through a nozzle system that
pellant hydrofluoroalkane (HFA)
produces the mist
• Commonly used with a spacer to help assist in coordination of
– Since the mist lasts longer than many pMDIs, there is less
concern for problems with coordination of actuation and
• Considered lower-resistance devices
• More appropriate in times of acute exacerbations when a patient
• Require less inhalation effort to deliver the medication to the
may not be able to generate adequate inspiratory flow necessary
for the use of alternate devices
• Must first be assembled which involves loading the cartridge into
• Prime before initial use by shaking the device and spraying four
the inhaler and writing the discard date of 3 months from when
pumps into the air
the cartridge is loaded
• For daily use, pMDIs are shaken and residents should be in-
• Must be primed prior to first use
structed to exhale completely, then wrap lips around mouthpiece,
• Daily use involves turning the clear base, opening the cap, in-
inhale a slow deep breath, remove device from mouth, and hold
structing the resident to breathe out completely and then placing
breath for as long as they can comfortably, or up to 10 seconds
lips around mouthpiece, followed by pressing the dose release
button as the resident takes a slow deep breath, removing the
– ProAir, Proventil, Ventolin, Xopenex, Advair HFA, Dulera, Sym-
device from mouth, and having the resident continue to breathe
bicort HFA, Flovent HFA, Asmanex HFA, Serevent HFA
in and hold breath for 10 seconds or as long as comfortable
DRY POWDER INHALERS (DPI)
– Spiriva Respimat, Stiolto Respimat, Combivent Respimat,
• Available in several different device styles that might be very
Striverdi Respimat
familiar to both nurses and residents
– The unit dose system utilizes a capsule containing the drug in With all of these devices, it is important to remember the fundamen-
powder form along with a corresponding specialized delivery
tal basics that help to ensure appropriate medication administration:
• Label each device when it is opened
– Multiple doses within the device are delivered once the dose
• Refer to expiration guidelines to determine a beyond-use date
is triggered and the device is activated, such as in a Diskus®
• pMDIs should be inspected before use and discarded if the count
is at zero in order to ensure appropriate dose delivery, even if it
• Do not utilize a propellant or require as vigilant coordination
between actuation of the device and inhalation
• Assist residents to rinse their mouth and spit out the water after
– Rely on the quick, deep breath of the resident in order to
inhaling a corticosteroid to help prevent oral thrush
aerosolize the drug for delivery
• Sequence inhalers so that bronchodilators are administered prior
– If a resident is not able to generate adequate inspiratory
to steroids in order to optimize inhaled steroid therapy
flow, the drug may not be delivered optimally via a DPI - this
should be brought to the attention of the resident's care team
Residents depend on our expertise in properly delivering medica-
• Require more attentive handling once the dose is loaded and the
tions through each of these various types of inhalers.
device is activated in order to avoid displacing the medication
– For the unit dose systems, there should be a noticeable
whirring noise upon inhalation --an absence of this noise may
Capstick TG, Clifton IJ. Inhaler technique and training in people with chronic obstructive pul-
monary disease and asthma. Expert Rev Respir Med. 2012 Feb;6(1):91-101; quiz 102-3. doi:
be an indication of inadequate inspiratory flow, or that the
10.1586/ers.11.89. Review. PubMed PMID: 22283582.
2 the Remedi Pulse August 2015
continued on next page
Stop the Madness: Rational Medication Administration Times
Prepared by: Jennifer Hardesty, Pharm.D., Chief Clinical Officer
The seemingly endless medpass cycle-starting early at 6 a.m. and
however, an extended-release risedronate (Atelvia) can be
often going until midnight, can be challenging to both residents
given immediately after breakfast
and staff alike! Numerous medication passes can tie up facility
• Change resident to a once-weekly or once-monthly formu-
staff, and can adversely affect resident quality of life by producing
interruptions of activities and disrupting important sleep time. By
promoting a resident-centered, rational medpass schedule, indi-
THE "HEAVY" MEDICATION PASS
vidual preferences and quality of life can be preserved while still
The heaviest medication pass of the day is traditionally the time
achieving good clinical outcomes.
that is assigned to "Once Daily" in your facility. Blood pressure
medications, stool softeners, vitamins/minerals, cholesterol
THE EARLY MORNING MEDICATION PASS
medications, antidepressants- most of the "QD" medications
Several medications have traditionally been administered very
are slated for this medpass. Staff often times have so many
early in the morning. Synthroid, Proton Pump Inhibitors, and
medications to administer and document that they run behind
Bisphosphonates (alendronate, risedronate), are often scheduled
or may be tempted to take shortcuts; and residents have
anywhere from 6 a.m. - 8 a.m., but these administration times may
numerous medications to swallow. Consider "re-balancing" the
require staff to wake a resident early, just to take a medication. For
medpass by doing the following:
those residents who prefer to sleep in, or are more challenging in
the morning - consider these options:
• Move vitamin, mineral, and herbal supplements to a med-
pass later in the day
Proton Pump Inhibitors
• Consolidate various vitamin and mineral supplements into a
• Some medications in this class may be given without regard to
food (e.g., pantoprazole and rabeprazole)
• Administer docusate or other routine bowel medications at
• For certain residents you may want to consider administering
the drug 30-60 minutes prior to lunch or dinner to achieve an
empty stomach, as opposed to breakfast
LATE NIGHT MEDICATION PASS
• Give medication with breakfast, but monitor efficacy closely for
As a general rule of thumb, you should re-evaluate the rationale
of any routine medication order administered after 9 p.m. In
certain circumstances a strict dosing schedule may be required
(e.g., Parkinson's Disease, pain management, antibiotics, etc.).
• While Synthroid is best absorbed on an empty stomach, it can
A risk-vs.-benefit assessment should be performed for any
be administered any time of day as long as it is given under
medication therapy that may interrupt or impede a resident's
the same conditions each day
sleep. Those artificial tears Q2H can wait until morning!
• For example, it can be given with breakfast as long as it is
always given with breakfast
A FINAL NOTE:
• Alternatively, administer Synthroid 30 minutes prior to dinner,
If you choose to alter the administration time away from the
or at bedtime to achieve the empty stomach condition
standard, consider a statement in the resident's record such
as, "I have evaluated the risk‐vs.‐benefit of administering
DRUGXYZ at 6 a.m., and determined resident quality of life
• Medications such as alendronate or risedronate should always
may be impacted adversely by waking him/her too early. Please
be given on an empty stomach in the morning with a full glass
administer the medication at 8 a.m." By doing what is best for
of water, the resident sitting upright to avoid adverse GI effects
the resident and documenting your rationale, you ensure good
• Administration time of this class of medication is not flexible;
clinical care with transparent justification.
Understanding Inhalers (cont'd)
"Respimat Insight." Respimat. Boehringer Ingelheim, n.d. Web. 12 July 2015. <https://www.
"How to Use Inhalers." UPMC. University of Pittsburgh Schools of the Health Sciences,
2011. Web. 12 July 2015. <http://www.upmc.com/patients-visitors/education/breathing/
the Remedi Pulse August 2015 3
Nurse of the MonthKATHY WOODINGTON, LPNSt. Mary's Nursing Center, Leonardtown, MD
CONGRATULATIONS to Kathy Woodington, LPN, Charge Nurse
at St. Mary's Nursing Center, Leonardtown, MD, for being chosen
Remedi acknowledges a "Nurse of the Month" in each of our
as the Remedi "Nurse of the Month." Kathy was nominated by
newsletters. DONs/ADONs/LNHAs, now is the time for you to
her Unit Manager, Carrie Sager, RN. Per Carrie, "Kathy has been
reward the nurse(s) at your facility, who exemplify excellence in
a nurse for 35 years and has worked full-time at St. Mary's for 15
nursing practice. The "Nurse of the Month" will receive an award
years on the night shift while also working as a medical records
and a certificate of commendation from Remedi. Please submit the
reviewer part-time. She is extremely thorough in her work and
following information: nominated nurse's name/title, facility
takes pride in all that she does. Kathy is very skilled with the
name, state, years at facility, years of experience and why this
use of My Remedi not only for order entry, but also utilizes a
nurse should be chosen, such as leadership abilities, clinical
variety of reports available to complete 24-hour checks, verify
expertise, teamwork, professional and personal strengths.
order completeness, and to do her job effectively and efficiently.
She consistently makes positive contributions to the care of all
Email your Nurse of the Month nomination(s) by the 30th of the
residents, is dedicated to her residents and treats them with the
month to [email protected]. Nurses Rock!!
utmost respect. Kathy is a tremendous asset to Unit 2.
continued from page 1
frame and perform a critical analysis of the entire clinical picture
or accepted professional standard and principles.2 Facilities
before citing a timing error. Facilities should undertake a similar
frequently and appropriately develop policies and procedures
analysis, if cited, to determine if the deficiency should be disput-
which exceed regulatory requirements as they strive to deliver
exceptional care to their residents. Provider's should consider
disputing medication error related deficiencies which are cited
In 2011, the Institute for Safe Medication Practices examined the
based on criteria other than that which is established by CMS.
issue of medication timing in the acute care setting and came to
two important conclusions. It was determined that "relatively few
The timing of medication administration, as is the case with all
medications truly require exact timing of doses" and that "many
services provided in a long-term care facility, should be deter-
nurses reported feeling great pressure to take shortcuts to comply
mined based on a resident-centered approach to care.
with the [timing] rule, which … led to errors, some harmful." ISMP
developed guidelines for the timely administration of medications
Note: Bill was a surveyor with the Maryland State Survey Agency
from 1988 until 2001. He became Chief Nurse of the agency in 2001
while they were intended for use in the acute care setting, they
and remained in that position until joining Remedi SeniorCare in 2013.
certainly contain principles that are applicable to long-term care.
1State Operations Manual: Appendix PP - Guidance to Surveyors for Long-Term Care
POLICIES AND PROCEDURES
Facilities: F 332
A review of several hundred deficiencies from multiple states
2 State Operations Manual: Appendix PP - Guidance to Surveyors for Long-Term Care
cited at F332 (medication error rate > 5%) during 2014 revealed
Facilities: F 332
that surveyors often use a facility's own policies and procedures
to establish or confirm that a medication error occurred. While
examining such documents may have merit in the survey pro-
cess, non-compliance with a policy or procedure does not in and
of itself meet CMS's definition of a medication error. A medica-
tion error is the failure to administer medication in accordance
with the prescriber's order, the manufacturer's specification, and/
4 the Remedi Pulse August 2015
Source: http://www.leadingagevirginia.org/files/public/Legislative%20E-Station/2015%20Legislative%20Newsletter/News%20August/2015-08_Pulse-2.pdf
Aprile, G. & C.Bertonatti. 1996. Manual sobre rehabilitación de fauna. Bol.Téc.FVSA, Buenos Aires. Boletín Técnico Nº 31 Manual sobre Rehabilitación de Fauna Proyecto Rehabilitación de Fauna del Programa Control del Comercio de Vida Silvestre Gustavo Aprile y Claudio Bertonatti FUNDACIÓN VIDA SILVESTRE ARGENTINA
Asian J Androl 2006; 8 (2): 219–224 .Clinical Experience .Long-term treatment with intracavernosal injections in diabetic men with erectile dysfunction P. Perimenis, A. Konstantinopoulos, P. P. Perimeni, K. Gyftopoulos, G. Kartsanis, E. Liatsikos, A. Athanasopoulos Department of Urology, University Hospital, 26500 Patras, Greece Aim: To assess the behavior of patients with diabetes mellitus (DM) and erectile dysfunction (ED) during 10 con-secutive years of treatment with self-injection of vasoactive drugs. Methods: Thirty-eight diabetic men, including 12with type I and 26 with type II diabetes, were followed up regularly for 10 years after they began self-injecting forsevere ED. Real time rigidity assessment was used for the objective determination of the initial dosage and then doseswere regulated in order to introduce an erection suitable for penetration and maintenance of erection for approximately30 min. Patients were followed up every two months, and doses were increased only when the treatment responsewas not satisfactory. Results: The number of injections used per year by the patients was reduced each year (meannumbers: 50 in the first year and 22.5 in the 10th) and treatment shifted towards stronger therapeutic modalities(mixtures of vasoactive drugs instead of prostaglandin E1 alone). Type I diabetic men were standardized to a level oftreatment as early as 5 years after the initiation of treatment. That level was finally reached by type II patients afteranother 4-5 years. Conclusion: Treatment with self-injections of vasoactive drugs in diabetic men with severe ED isa safe and effective alternative in the long term. Diabetic men of both types show the same preferences in quality andquantity of treatment after 10 years. The key point for maintenance in treatment is the adjustment of the therapeuticmethod and dosage to optimal levels for satisfactory erections. (Asian J Androl 2006 Mar; 8: 219–224)